Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-160984
Filing Date
2022-05-26
Accepted
2022-05-26 16:06:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d342375ddefa14a.htm DEFA14A 53376
2 GRAPHIC g342375g01a02.jpg GRAPHIC 40884
  Complete submission text file 0001193125-22-160984.txt   106786
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35890 | Film No.: 22969954
SIC: 2834 Pharmaceutical Preparations